Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01562275
Title A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Patients With Locally Advanced or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech
Indications
Therapies
Age Groups: adult
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Boston Massachusetts 02215 United States Details
Detroit Michigan 48201 United States Details
Nashville Tennessee 37203 United States Details
Barcelona 08035 Spain Details
Valencia 46010 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field